Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations

Completed

• Conditions: ANEMIA

• Registration Number: NCT01903148
• Lead Sponsor: Fundación Senefro

Brief Summary

The purpose of this study is to evaluate the impact of the last recommendations of the European Anemia Working Group ERBP in the anemia management in the achievement of the therapeutic goal of Hb 11-12 g/dL.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-10
• Primary Completion: 2012-06
• Study Completion: 2012-06
• Study First Submitted: 2013-07-12
• Study First Submitted QC: 2013-07-18
• Study First Posted: 2013-07-19
• Results First Submitted: 2013-08-22
• Status Verified: 2013-11
• Results First Submitted QC: 2013-11-08
• Last Update Submitted: 2013-11-08
• Results First Posted: 2014-01-01
• Last Update Posted: 2014-01-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 455

Inclusion Criteria

• Adults patients with anemia secondary to chronic kidney disease (CKD) not on dialysis.
• Patients starting anemia treatment (naïve) after six months of the last recommendations of the European Anemia Working Group ERBP (January 2011).
• Patients in treatment who changed from previous ESA treatment since January 2011 (converted patients

Exclusion Criteria

• Patients in Erythropoiesis Stimulating Agents (ESA) dose adjustment period.
• Kidney transplant patients.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
% Patients Achieving Target Hemoglobin Levels	1 day because is a crosssectional study with only a visit	% patients with Hb levels between 11-12 mg/dl

Secondary Outcome Measures

Name	Time	Method
Hemoglobin Levels Per Type of Patients	1 day	levels Hb and type of patients
Patients With Hb>12	1 day
% Patients With Erythropoiesis Stimulating Agents (ESA) Therapy	1 day	know the treatments ESA for maintenance of hb levels
Iron Treatment	1 day	Patients with supplementary Iron treatment to ESA
Patients With Hb<11	1 day

Trial Locations

Locations (29)

Hospital Puerto Real; 🇪🇸 Cadiz, Andalucía, Spain

Hospital de Jerez; 🇪🇸 Jerez, Andalucía, Spain

Clínico V. Victoria; 🇪🇸 Malaga, Andalucía, Spain

Hospital Marques de Valdecilla; 🇪🇸 Santander, Cantabria, Spain

Hospital Virgen de la Luz; 🇪🇸 Toledo, Castilla la Mancha, Spain

Fundación Puigvert; 🇪🇸 Barcelona, Cataluña, Spain

Hospital Bellvige; 🇪🇸 Barcelona, Cataluña, Spain

Hospital Bellvitge; 🇪🇸 Barcelona, Cataluña, Spain

Hospital Clinic; 🇪🇸 Barcelona, Cataluña, Spain

Hospital Germans Trias i Pujol; 🇪🇸 Barcelona, Cataluña, Spain

Scroll for more (19 remaining)